via NBAA
The FAA has announced significant updates to its medical certification policies for pilots using certain antidepressants and insulin, aiming to streamline the approval process while maintaining safety.
Under the revised policy, pilots who use a broader range of modern antidepressant medications may now be considered for medical certification through an expanded protocol that evaluates individual stability and treatment response. The FAA has also modernized its approach for insulin-treated diabetes, incorporating newer continuous monitoring technologies and risk-based assessment tools. These changes are intended to reduce delays, reflect current medical capabilities, and make certification more accessible for pilots managing well-controlled conditions under close supervision from aviation medical examiners.
» Full Story: NBAA
